Covered recipient · General Payments record
ALEXUS MIRANDA
General Payments · PY2025
$608.35
- Reported across 14 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $608.35 | 14 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Corcept Therapeutics | $162.74 | 1 |
| CHIESI USA, INC. | $146.96 | 1 |
| Novo Nordisk AS | $121.03 | 2 |
| Amgen Inc. | $51.46 | 3 |
| E.R. Squibb & Sons, L.L.C. | $50.34 | 3 |
| Soleno Therapeutics, Inc. | $25.36 | 1 |
| Celgene Corporation | $22.52 | 1 |
| MannKind Corporation | $14.00 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.94 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $608.35 | 14 |
Payment records · PY2025 (14)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $18.78 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229736519 | CMS |
| Amgen Inc. | $14.68 | 11/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229736509 | CMS |
| Amgen Inc. | $18.00 | 11/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229736530 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.94 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222749760 | CMS |
| Celgene Corporation | $22.52 | 07/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184482471 | CMS |
| Chiesi USA, Inc. | $146.96 | 12/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242173933 | CMS |
| Corcept Therapeutics | $162.74 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214138343 | CMS |
| E.R. Squibb & Sons, L.L.C. | $21.86 | 09/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184482483 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.19 | 11/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184482491 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.29 | 11/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184482493 | CMS |
| Mannkind Corporation | $14.00 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250890603 | CMS |
| Novo Nordisk Inc | $91.13 | 04/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189090350 | CMS |
| Novo Nordisk Inc | $29.90 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188958764 | CMS |
| Soleno Therapeutics, Inc. | $25.36 | 09/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241823543 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.